SILVER LIFE CO.,LTD. (9262) AI Stock Analysis

• Market Cap: ¥9.39B
• Dividend Yield: 1.87%
• Average Volume (3M): 37.85K
• Price to Earnings (P/E): 13.4
• Beta (1Y): 0.71
• Revenue Growth: 10.06%
• EPS Growth: 4.96%
• Country: JP
• Employees: 305
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Personal Products & Services
• EPS (TTM): 20.65
• Shares Outstanding: 10,907,600
• 10 Day Avg. Volume: 21,360
• 30 Day Avg. Volume: 37,850
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 75 Outperform
• Price Target: ¥975.00 ▲(14.04% Upside)

Silver Life Co., Ltd. has a solid overall stock score driven by strong financial performance and positive technical indicators. The company's reasonable valuation further supports its attractiveness. While there is room for improvement in profitability and cash flow conversion, the stock's current momentum and fair valuation make it a compelling option in the Personal Products & Services industry.

SILVER LIFE CO.,LTD. Business Overview & Revenue Model

Company Description

SILVER LIFE CO., LTD. (9262) is a company based in Japan that operates primarily in the healthcare and wellness sectors. The company focuses on providing health management services and products that cater to the aging population, including health supplements, medical equipment, and lifestyle support services. SILVER LIFE aims to enhance the quality of life for senior citizens through innovative solutions tailored to their needs.

How the Company Makes Money

SILVER LIFE generates revenue primarily through the sale of health supplements and medical devices designed for elderly care. The company also provides subscription-based health management services and partners with healthcare institutions and insurance companies to offer integrated health solutions. Key revenue streams include direct product sales, service subscriptions, and partnerships that may involve co-marketing agreements or bundled service offerings. Additionally, SILVER LIFE may benefit from government initiatives aimed at improving senior health care, creating further opportunities for earnings.

SILVER LIFE CO.,LTD. Financial Statement Overview

Summary

SILVER LIFE CO.,LTD. shows strong revenue growth and a healthy balance sheet with low leverage. However, concerns arise from the lack of recent cash flow data and a slight decline in EBIT. Overall, the company has a robust financial foundation.

Income Statement

SILVER LIFE CO.,LTD. has shown strong revenue growth, increasing from ¥8,832 million in 2020 to ¥14,091 million in TTM (Trailing-Twelve-Months). Gross Profit Margin is healthy at 32.8%, and the Net Profit Margin has improved to 4.4%. The company's EBIT and EBITDA margins are stable at 5.1% and 11.7% respectively, indicating efficient operations. However, there is a slight decline in EBIT from the previous period, which could be a point of concern.

Balance Sheet

The balance sheet reflects a strong equity position with a Debt-to-Equity Ratio of 0.28, suggesting low leverage risk. The Return on Equity (ROE) is solid at about 9.4%, indicating efficient use of equity. The Equity Ratio is robust at approximately 66.3%, showcasing a strong financial structure with significant equity backing.

Cash Flow

Cash flow analysis reveals some concerns due to the absence of operating and free cash flow data in the latest TTM. Historically, the company has shown fluctuating free cash flow growth, with a significant drop in the latest periods. The Operating Cash Flow to Net Income ratio was strong previously but is currently unavailable, indicating potential volatility in cash generation.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	14.09B	14.92B	13.56B	12.27B	11.22B	10.05B
Gross Profit	4.62B	5.03B	4.37B	3.71B	3.09B	2.72B
EBITDA	1.65B	1.95B	1.74B	1.53B	1.21B	1.19B
Net Income	621.33M	702.58M	668.05M	602.57M	401.89M	546.11M
Balance Sheet
Total Assets	9.92B	10.45B	9.88B	9.56B	8.86B	8.26B
Cash, Cash Equivalents and Short-Term Investments	1.34B	1.60B	1.27B	1.51B	1.47B	1.47B
Total Debt	1.85B	1.69B	1.71B	1.95B	2.19B	1.93B
Total Liabilities	3.34B	3.48B	3.45B	3.65B	3.56B	3.34B
Stockholders Equity	6.58B	6.97B	6.42B	5.92B	5.30B	4.93B
Cash Flow
Free Cash Flow	0.00	613.25M	152.13M	242.61M	-329.89M	-2.33B
Operating Cash Flow	0.00	1.52B	1.32B	1.20B	1.21B	369.40M
Investing Cash Flow	0.00	-1.00B	-1.16B	-937.87M	-1.47B	-2.69B
Financing Cash Flow	0.00	-185.57M	-400.55M	-230.88M	263.50M	1.95B

SILVER LIFE CO.,LTD. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 855.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9262, the sentiment is Neutral. The current price of 855 is below the 20-day moving average (MA) of 877.10, above the 50-day MA of 821.70, and above the 200-day MA of 739.61, indicating a neutral trend. The MACD of 12.69 indicates Positive momentum. The RSI at 51.13 is Neutral, neither overbought nor oversold. The STOCH value of 21.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9262.

SILVER LIFE CO.,LTD. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7358	76 Outperform	¥14.36B	15.76	―	2.65%	7.89%	-12.90%
9262	75 Outperform	¥9.39B	13.41	―	1.87%	10.06%	4.96%
2485	74 Outperform	¥11.30B	9.33	―	3.93%	25.26%	65.66%
7040	71 Outperform	¥5.79B	6.92	―	3.49%	2.08%	-30.72%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
7578	41 Neutral	¥2.17B	―	―	―	-18.74%	-1062.47%

SILVER LIFE CO.,LTD. Corporate Events

SILVER LIFE CO., LTD. Reports Mixed Financial Results for Nine Months Ending April 2025

SILVER LIFE CO., LTD. reported its non-consolidated financial results for the nine months ending April 30, 2025, showing a slight increase in net sales by 8.7% compared to the previous year. However, the company experienced a decline in ordinary profit and net income by 5.1% and 5.7%, respectively. Despite these challenges, the company maintains a strong capital adequacy ratio of 66.4% and plans to increase its year-end dividend to 16 yen per share, indicating confidence in its financial stability and commitment to returning value to shareholders.